Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Nature Health|June 1, 2026
Mapping the local effectiveness of mass drug administration for malaria using transportability methodsMichelle E Roh, Yanwei Tong, Gabriella Barratt Heitmann, et al.
Clinical Pharmacology and Therapeutics|October 15, 2024
Drug-Drug Interaction Between Dihydroartemisinin-Piperaquine and Sulfadoxine-Pyrimethamine During Malaria Chemoprevention in Pregnant WomenNorah Mwebaza, Michelle E Roh, Yourong Z Geng, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Impact of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine on sexually transmitted and reproductive tract infections: results from a randomised trial in UgandaHarriet Adrama, Erin J Dela Cruz, Nida Ozarslan, et al.
Plos Medicine|September 18, 2025
Dihydroartemisinin-piperaquine plus sulfadoxine-pyrimethamine versus either drug alone for intermittent preventive treatment of malaria in pregnancy: A double-blind, randomized, controlled phase 3 trial from UgandaAbel Kakuru, Jimmy Kizza, Miriam Aguti, et al.
International Journal of Epidemiology|February 9, 2026
Impact of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine on sexually transmitted and reproductive tract infections: results from a randomized trial in UgandaHarriet Adrama, Erin J Dela Cruz, Nida Ozarslan, et al.
Malaria Journal|December 30, 2025
Maternal and household risk factors for malaria in pregnancy and low birthweight: a prospective cohort study from UgandaMiriam Aguti, Jimmy Kizza, Abel Kakuru, et al.
Trials|October 15, 2025
FocaL mass drug administration for Plasmodium vivax malaria elimination (FLAME): study protocol for an open-label cluster randomized controlled trial in PeruSydney R Fine, Veronica Soto Calle, Astrid Altamirano Quiroz, et al.
Research Square|September 26, 2025
Maternal and household risk factors for malaria in pregnancy and low birthweight: a prospective cohort study from UgandaMiriam Aguti, Jimmy Kizza, Abel Kakuru, et al.
Plos Medicine|August 14, 2025
The transmission blocking activity of artemisinin-combination, non-artemisinin, and 8-aminoquinoline antimalarial therapies: A pooled analysis of individual participant dataLeen N Vanheer, Jordache Ramjith, Almahamoudou Mahamar, et al.
The Lancet. Infectious Diseases|February 10, 2018
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trialAlassane Dicko, Michelle E Roh, Halimatou Diawara, et al.
Pageof 5